Publication | Closed Access

Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice

InflammationVascular DiseaseOxysterolCardiovascular DiseaseMedicineVascular PharmacologyPhysiologyEndothelial DysfunctionLipid PeroxidationVascular BiologyApolipoprotein E-deficient MicePharmacologyAtherosclerosisOxidative Stress